Oral antihistamines for the symptom of nasal obstruction in persistent allergic rhinitis - A systematic review of randomized controlled trials

Clinical and Experimental Allergy

Volumn 35, Issue 2, 2005, Pages 207-212

  Hore, Ian ^a,c   Georgalas, C ^b   Scadding, G ^a  

^a ROYAL NATIONAL THROAT NOSE AND EAR HOSPITAL   (United Kingdom)

^b WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

Meta analysis; Nasal obstruction; Oral antihistamines; Persistent allergic rhinitis; Randomized controlled trial; Symptom score; Systematic review

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; CETIRIZINE; CLEMASTINE; EBASTINE; FEXOFENADINE; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; LORATADINE; MIZOLASTINE; PLACEBO; TERFENADINE;

ALLERGIC RHINITIS; CLINICAL TRIAL; COCHRANE LIBRARY; DRUG EFFICACY; EMBASE; FATIGUE; HEADACHE; HEALTH CARE PERSONNEL; HUMAN; MEDLINE; META ANALYSIS; NOSE OBSTRUCTION; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SYMPTOM; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; DOUBLE-BLIND METHOD; HISTAMINE H1 ANTAGONISTS; HUMANS; MIDDLE AGED; NASAL OBSTRUCTION; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS; RHINITIS, ALLERGIC, PERENNIAL; TREATMENT OUTCOME;

EID: 14844367073     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2005.02159.x     Document Type: Review

References (25)

1. Allergic Rhinitis and its Impact on Asthma Workshop Expert Panel in collaboration with World Health Organization, Management of allergic rhinitis and its impact on asthma. A pocket guide for physicians and nurses. MCR Vision 2001. http://www. mcrvisionstore.com
2. Jones NS, Carney AS, Davis A. The prevelance of allergic rhinosinusitis: a review. J Laryngol Otol 1998; 112:1019-30.
3. Bousquet J. and the Allergic Rhinitis and its Impact on Asthma (A.R.I.A.), Workshop Group in collaboration with World Health Organization. A.R.I.A. Workshop Report Introduction. J Allergy Clin Immunol 2001; 108 (Suppl.):S148-9.
4. Cauwenberge P, van Bachert C, Passalacqua G et al. Consensus statement on the treatment of allergic rhinitis. Allergy 2000; 55:116-34.
5. Scadding GK. Desloratidine in the treatment of nasal congestion in seasonal allergic rhinitis: preclinical and clinical evidence. Clin Drug Invest 2002; 22 (Suppl. 2):21-32.
6. Greenhalgh T. How to read a paper. The basics of evidence based medicine. BMJ Publishing, 1997.
7. J Allergy Clin Immunol searched from January 1992 to June 2002.
8. The week of the nose. The XVI Congress of the European Rhiniologic Society XV ISIAN VIII Congress of the International Rhinologic Society, Ghent, Belgium, 8-12 September 1996.
9. The XVII International Congress of Allergology and Clinical Immunology, Sydney, Australia, 15-20 October 2000.
10. British National Formulary, Issue 41, 2002. The British Medical Associaton and Royal Pharmaceutical Society of Great Britain. http://www.bnf.org
11. Egger M, Smith GD, Altman DG. Systematic reviews in health care, meta-analysis in context. BMJ Books, 2001.
12. Clarke M, Oxman AD, eds. In: Cochrane Reviewers' Handbook 4.1.5 [updated April 2002]; Appendix 5a, Issue 2. Oxford: The Cochrane Library, 2002, Update Software, updated quarterly.
13. Malm L. Measurement of nasal patency. Allergy 1997; 52 (Suppl. 40):19-23.
14. Bousquet J, Gaudano EM, Palma Carlos AG, Staudinger H. A twelve-week placebo-controlled study of the efficacy and safety of Ebastine, 10 and 20 mg once daily in the treatment of perennial allergic rhinitis. Multicentre Study Group. Allergy 1999; 54: 562-8.
15. Bruttmann G, Charpin D, Germouty J, Horak F, Kunkel G, Wittmann G. Evaluation of the efficacy and safety of Loratidine in perennial allergic rhinitis. J Allergy Clin Immunol 1989; 83:411-6.
16. Manasmann HC Jr, Altman RA, Berman BA et al. Efficacy and safety of Cetirizine therapy in perennial allergic rhinitis. Ann Allergy 1992; 68:348-53.
17. Bachert C, Brostoff J, Scadding GK, Tasman J, Stalla-Bourdillon A, Murrieta M. Mizalastine therapy also has an effect on nasal blockage in perennial allergic rhino-conjunctivitis. Riperan Study Group. Allergy 1998; 53:969-75.
18. Bruttmann G, Arendt C, Bernheim J. Double-blind placebo controlled comparison of Cetirizine 2HCl and Terfenadine in atopic perennial rhinitis. Acta Ther 1989; 15:99-109.
19. Ciprandi G, Cosentino C, Milanese M, Mondino C, Canonica GW. Fexofenadine reduces nasal congestion in perennial allergic rhinitis. Allergy 2001; 56:1068-70.
20. Frolund L, Etholm B, Irander K et al. A multicentre study of Loratadine, Clemastine and placebo in patients with perennial allergic rhinitis. Allergy 1990; 45:254-61.
21. Potter PC. on behalf of the Levocetirizine Study Group Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites. Allergy 2003; 58:893.
22. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991; 337:867-72.
23. Dickersin K, Min Yl, Meinert CL. Factors influencing publication of research results. J Am Med Assoc 1992; 267:374-6.
24. Stern JM, Simes RJ. Publication bias: evidence of delayed publication in a cohort study of clinical research projects. Br Med J 1997; 315:640-5.
25. Olson CM, Rennie D, Cook D et al. Publication bias in editorial decision making. J Am Med Assoc 2002; 287:2825-8.